Home › NDC Lookup › RxCUI directory › RxCUI 2122642

{9 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 9 Tablet Pack] — RxCUI 2122642

RxNorm drug concept · Brand name pack
RxCUI 2122642 Brand name pack · BPCK ● Current RxNorm concept 1 FDA product 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2122642
Official name{9 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 9 Tablet Pack]
Concept typeBrand name pack (BPCK)
RxNorm statusCurrent RxNorm concept
Also known asMavenclad 9 Tablet Pack
FDA products mapped1
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cladribine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's actually both, depending on the form. The oral tablets (brand name Mavenclad) are approved to treat relapsing forms of multiple sclerosis in adults — specifically for people w...
  • What exactly is cladribine used for — is it a chemotherapy or an MS drug?
  • Not exactly like a daily pill. The oral tablets are taken in a structured course — two yearly treatment courses, and each course is split into two short cycles of daily dosing. So...
  • How do I actually take the MS tablets — do I take them every day?
📖 Read our full Cladribine guide →

🕸️ Concept Web — How {9 (cladribine 10 MG Oral Tablet [Mavenclad]) }... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {9 (cladribine 10 MG Oral Tablet [Mavenclad]) } Pack [Mavenclad 9 Tablet Pack] RxCUI 2122642

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cladribine 44157
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mavenclad 2122636
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cladribine Oral Tablet 2122633
    • Cladribine Oral Product 2122631
    • Cladribine Pill 2122632
    • Cladribine Oral Tablet [Mavenclad] 2122638
    • Mavenclad Oral Product 2122639
    • Mavenclad Pill 2122640
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Cladribine 10 MG Oral Tablet [Mavenclad] SBD · 2122641
  • Cladribine 10 MG [Mavenclad] SBDC · 2122637
  • Cladribine Oral Tablet [Mavenclad] SBDF · 2122638
  • Mavenclad Oral Product SBDG · 2122639
  • Mavenclad Pill SBDG · 2122640
  • Mavenclad BN · 2122636

📦 FDA Products & Package NDCs

1 product · 7 package NDCs
7 package NDCs map to RxCUI 2122642 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
44087-4000-00 5 BLISTER PACK in 1 CARTON (44087-4000-0) / 2 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-04 4 BLISTER PACK in 1 CARTON (44087-4000-4) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-05 5 BLISTER PACK in 1 CARTON (44087-4000-5) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-06 6 BLISTER PACK in 1 CARTON (44087-4000-6) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-07 7 BLISTER PACK in 1 CARTON (44087-4000-7) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-08 8 BLISTER PACK in 1 CARTON (44087-4000-8) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
44087-4000-09 9 BLISTER PACK in 1 CARTON (44087-4000-9) / 1 TABLET in 1 B... Mavenclad EMD Serono, Inc. 2019-04-01
Observed labelers: EMD Serono, Inc. (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.